Tagged with UAE

MENA The Middle East and North Africa (MENA) region’s pharmaceutical market is projected to reach a value of around USD 60 billion by 2025 according to reporting from TradeArabia. The most impressive growth is coming from the UAE, but North African giants Egypt and Algeria are also significant contributors.   Factors…

UAE How quickly can a country truly transform its healthcare system, while making it sustainable for the future? The mindset of Emiratis is that anything that is feasible and beneficial for the country should and will be done, regardless of the cost. This is why health authorities have been moving at…

UAE “Over the past twenty years, we have seen a drastic change in the socio-economic climate of the Gulf region and neighboring countries. There has been considerable growth in terms of wealth and a sharp increase in health expenditures, which was mandated by the Ministry of Health”, explains Ayman Sahli, CEO…

UAE Amin Al Amiri, Assistant undersecretary for Medical Practice and Licensee of Ministry of Health, UAE, discusses why the UAE, despite turmoil in the rest of the Middle East region, continues to be a destination for the pharmaceutical industry, how MOH plans on supporting standardization across the region, and how recruiting…

UAE Mohammed Zafrullah, VP & General Manager of GlaxoSmithKline (GSK) Pharmaceuticals, argues that the UAE, despite recent turmoil in the rest of the Middle East, is the perfect emerging country to do build a business in due to the many opportunities for innovation and growth.   To have a successful business,…

UAE Dr Omar Ghosheh, Chief Executive Officer of Dimensions Healthcare, examines what it takes to build a company in Dubai, why it is the perfect city for healthcare companies and why patience always pays off in the end.   What are the main services that Dimensions is known for? It’s a…

Lilly Huzur Devletsah, General Manager of the Gulf and Near East regions of Lilly, talks about the political instability in other parts of the region, the lack of an adequate talent pool in the industry, and what this all means for the future growth of Lilly.   With the inauguration of…

UAE Ayman Sahli, CEO of Julphar Pharmaceuticals, gives his insight into the region’s growing health problems related to lifestyle changes and what this means for the company in the long run.    Under your leadership, Julphar has established itself as a leading pharmaceutical company in the Middle East. What are the…

UAE Marwan Abdulaziz, Executive Director of Dubiotech, talks about the growing Life Sciences industry in the UAE, why it is important for the government to encourage biotech studies in universities, and what the major industry challenges will look like over the next several years.   Dubiotech is the first free zone…

UAE Ashraf Allam, Regional Managing Director of Amgen, talks about the main challenges the company has faced, the benefit of building a company in the UAE, and the growth strategy of Amgen—past, present and future.   Amgen is a relative newcomer to the region having only established is operations in 2006.…

Roche Diagnostics Moritz Hartmann, Middle East General Manager of Roche Diagnostics, gives his insight on why Roche Diagnostics made the decision to set up shop in Dubai, what the main challengers in a developing market were and will be, and why the government has been so supportive of the company’s endeavors thus…

Newbridge Pharmaceuticals Joe Henein, President & CEO of Newbridge Pharmaceuticals, talks about the evolution of the company since his joining, what makes Newbridge Pharmaceuticals a unique partner within the industry, and expounds on the many possible options for the future of the company. Newbridge Pharmaceuticals is a unique company within the Middle…